Furthermore, it was reported that visit-to-visit HbA1c variability was a predictor of new-incident peripheral neuropathy [19], and that visit-to-visit glycated albumin variability was significantly associated with the risk of developing CAN in T2DM [23]. The gene discussed is ALB; the disease is type 2 diabetes mellitus.